Surgical treatment of bisphosphonate-associated osteonecrosis: Prognostic score and long-term results

Abu-Id, 2008, ‘Bis-phossy jaws’ – high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw, J Craniomaxillofac Surg, 36, 95, 10.1016/j.jcms.2007.06.008

Allen, 2009, Bisphosphonates and osteonecrosis of the jaw: moving from the bedside to the bench, Cells Tissues Organs, 189, 289, 10.1159/000151371

Allen, 2014, A review of pharmaceutical agents and oral bone health: how osteonecrosis of the jaw has affected the field, Int J Oral Maxillofac Implant., 29, e45, 10.11607/jomi.te41

Arce, 2009, Imaging findings in bisphosphonate-related osteonecrosis of the jaws, J Oral Maxillofac Surg, 67, 75, 10.1016/j.joms.2008.12.002

Bamias, 2005, Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors, J Clin Oncol, 23, 8580, 10.1200/JCO.2005.02.8670

Bartl, 2008, Einsatz der Bisphosphonate in der Orthopädie und Unfallchirurgie, Orthopäde, 37, 595, 10.1007/s00132-008-1280-y

Bartl, 2009, Medikamenteninduzierte Osteopathien. Medikamente, Pathogenese, Formen, Diagnostik, Prävention und Therapie, Orthopäde, 38, 1245, 10.1007/s00132-009-1436-4

Bedogni, 2008, Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 105, 358, 10.1016/j.tripleo.2007.08.040

Bianchi, 2007, Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 104, 249, 10.1016/j.tripleo.2007.01.040

Blus, 2013, Use of ultrasonic bone surgery (Piezosurgery) to surgically treat bisphosphonate-related osteonecrosis of the jaws (BRONJ). A case series report with at least 1 year of follow-up, Open Dent J, 7, 94, 10.2174/1874210601307010094

Boonyapakorn, 2008, Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies, Oral Oncol, 44, 857, 10.1016/j.oraloncology.2007.11.012

Borm, 2013, Risikobeurteilung von Patienten mit ossärer, antiresorptiver Therapie in der zahnärztlichen Praxis. Ein update, Schweiz Monatsschr Zahnmed, 123, 985

Boyd, 1993, Classification of mandibular defects, Plast Reconstr Surg, 92, 1266

Cafro, 2008, Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: definition and management of the risk related to zoledronic acid, Clin Lymphoma Myeloma, 8, 111, 10.3816/CLM.2008.n.013

Carlson, 2009, The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws, J Oral Maxillofac Surg, 67, 85, 10.1016/j.joms.2009.01.006

Carmagnola, 2013, Histological findings on jaw osteonecrosis associated with bisphosphonates (BONJ) or with radiotherapy (ORN) in humans, Acta Odontol Scand, 71, 1410, 10.3109/00016357.2013.765592

Cho, 2012, Histopathological features of bisphosphonate-associated osteonecrosis: findings in patients treated with partial mandibulectomies, Oral Surg Oral Med Oral Pathol Oral Radiol, 114, 785, 10.1016/j.oooo.2012.08.457

Conte Neto, 2013, Experimental development of bisphosphonate-related osteonecrosis of the jaws in rodents, Int J Exp Path, 94, 65, 10.1111/iep.12007

Corso, 2007, A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma, Leukemia, 21, 1545, 10.1038/sj.leu.2404682

Crooks, 1991, The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients, J Gerontol, 46, M139, 10.1093/geronj/46.4.M139

Eckert, 2007, Bisphosphonate-related jaw necrosis – severe complication in maxillofacial surgery, Cancer Treat Rev, 33, 58, 10.1016/j.ctrv.2006.09.003

Favia, 2009, Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy, Bone, 45, 406, 10.1016/j.bone.2009.05.008

Fleisch, 2007, Einführung in die Bisphosphonate. Geschichte und Wirkungsmechanismen, Orthopäde, 36, 103, 10.1007/s00132-006-1040-9

Fortuna, 2012, Multiple myeloma vs. breast cancer patients with bisphosphonates related osteonecrosis of the jaws: comparative analysis of response to treatment and predictors of outcome, J Oral Pathol Med, 41, 222, 10.1111/j.1600-0714.2011.01095.x

Francis, 2007, Historical perspectives on the clinical development of bisphosphonates in the treatment of bone diseases, J Musculoskelet Neuronal Interact, 7, 2

Gotcher, 1981, The progress of the periodontal syndrome in the rice rat. II. The effect of a diphosphonate on the periodontium, J Periodont Res, 16, 441, 10.1111/j.1600-0765.1981.tb00995.x

Grötz, 2010, Bei welchen Bisphosphonat-Patienten darf ich eigentlich implantieren? Ein systematisches Review, Z Zahnärztl Impl, 26, 153

Hanasono, 2013, Mandibulectomy and free flap reconstruction for bisphosphonate-related osteonecrosis of the jaw, JAMA Otolaryngol Head Neck Surg, 139, 1135, 10.1001/jamaoto.2013.4474

Hansen, 2006, Osteonecrosis of the jaws in patients treated with bisphosphonates – histomorphologic analysis in comparison with infected osteoradionecrosis, J Oral Pathol Med, 35, 155, 10.1111/j.1600-0714.2006.00391.x

Henriksen, 2009, Local communication on and within the bone controls bone remodeling, Bone, 44, 1026, 10.1016/j.bone.2009.03.671

Hoefert, 2010, Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw, J Oral Maxillofac Surg, 69, 362, 10.1016/j.joms.2010.06.200

Hoefert, 2010, Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings, Clin Oral Invest, 14, 271, 10.1007/s00784-009-0300-6

Hoff, 2008, Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates, J Bone Miner Res, 23, 826, 10.1359/jbmr.080205

Hokugo, 2010, Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats, J Bone Minera Res, 25, 1337, 10.1002/jbmr.23

Jaeger, 2010, Zelltherapie bei Knochenheilungsstörungen, Orthopäde, 39, 449, 10.1007/s00132-009-1583-7

Jakob, 2013, Grundlagen des Knochenstoffwechsels und pharmakologische Daten, MKG-Chirurg, 6, 72, 10.1007/s12285-012-0320-0

Kern, 2006, 10

Kikuiri, 2010, Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice, J Bone Miner Res, 25, 1668, 10.1002/jbmr.37

King, 2008, Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates, Pharmacotherapy, 28, 667, 10.1592/phco.28.5.667

Krishnan, 2009, Imaging findings of bisphosphonate-related osteonecrosis of the jaw with emphasis on early magnetic resonance imaging findings, J Comp Assist Tomogr, 33, 298, 10.1097/RCT.0b013e31817e4986

Kuroshima, 2013, Chemotherapeutic and antiresorptive combination therapy suppressed lymphangiogenesis and induced osteonecrosis of the jaw-like lesions in mice, Bone, 56, 101, 10.1016/j.bone.2013.05.013

Kuroshima, 2014, Early effects of parathyroid hormone on bisphosphonate/steroid-associated compromised osseous wound healing, Osteoporos Int, 25, 1141, 10.1007/s00198-013-2570-8

Landesberg, 2011, Potential pathophysiological mechanisms in osteonecrosis of the jaw, Ann N Y Acad Sci, 1218, 62, 10.1111/j.1749-6632.2010.05835.x

Lee, 2002, Bone adaptation to load: microdamage as a stimulus of bone remodelling, J Anat, 201, 437

Lemound, 2012, Bisphosphonate-associated osteonecrosis of the mandible: reliable soft tissue reconstruction using a local myofascial flap, Clin Oral Invest, 16, 1143, 10.1007/s00784-011-0596-x

Marx, 2003, Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic, J Oral Maxillofac Surg, 61, 1115, 10.1016/S0278-2391(03)00720-1

Marx, 2008, Uncovering the cause of ‘phossy jaw’ circa 1858 to 1906: oral and maxillofacial surgery closed case files-case closed, J Oral Maxillofac Surg, 66, 2356, 10.1016/j.joms.2007.11.006

Marx, 2012, Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease, Int J Oral Maxillofac Surg, 41, 283, 10.1016/j.ijom.2011.12.016

Marx, 2014, A decade of bisphosphonate bone complications: what it has taught us about bone physiology, Int J Oral Maxillofac Implant., 29, e247, 10.11607/jomi.te61

Mast, 2012, Incidence of maxillary sinusitis and oro-antral fistulae in bisphosphonate-related osteonecrosis of the jaw, J Cranio Maxillofac Surg, 40, 568, 10.1016/j.jcms.2011.10.012

Matsubara, 2005, Alveolar bone marrow as a cell source for regenerative medicine: differences between alveolar and iliac bone marrow stromal cells, J Bone Miner Res, 20, 399, 10.1359/JBMR.041117

Migliorati, 2003, Bisphosphonates and oral cavity avascular bone necrosis, J Clin Oncol, 22, 4253, 10.1200/JCO.2003.99.132

Miksad, 2011, Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw, Oncologist, 16, 121, 10.1634/theoncologist.2010-0183

Miles, 1972, Phosphorus necrosis of the jaw: ‘phossy jaw’, Br Dent J, 133, 203, 10.1038/sj.bdj.4802906

Mücke, 2011, Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaw, J Cancer Res Clin Oncol, 137, 907, 10.1007/s00432-010-0953-1

Nocini, 2009, Vascularised fibula flap reconstruction of the mandible in bisphosphonate-related osteonecrosis, Eur J Surg Oncol, 35, 373, 10.1016/j.ejso.2008.05.002

Ohbayashi, 2013, Adjunct teriparatide therapy with monitoring of bone turnover markers and bone scintigraphy for bisphosphonate-related osteonecrosis of the jaw, Oral Surg Oral Med Oral Pathol Oral Radiol, 115, e31, 10.1016/j.oooo.2012.09.006

O'Ryan, 2009, Intravenous bisphosphonate-related osteonecrosis of the jaw. Bone scintigraphy as an early indicator, J Oral Maxillofac Surg, 67, 1363, 10.1016/j.joms.2009.03.005

Otto, 2011, Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence – a multi-centre study, J Craniomaxillofac Surg, 39, 272, 10.1016/j.jcms.2010.05.009

Otto, 2012, Bisphosphonate-related osteonecrosis of the jaws – characteristics, risk factors, clinical features, localization and impact on oncological treatment, J Cranio Maxillofac Surg, 40, 303, 10.1016/j.jcms.2011.05.003

Paparella, 2011, Histopathological features of osteonecrosis of the jaw associated with bisphosphonates, Histopathology, 60, 514, 10.1111/j.1365-2559.2011.04061.x

Pautke, 2011, Fluorescence-guided bone resection in bisphosphonate-associated osteonecrosis of the jaws: first clinical results of a prospective pilot study, J Oral Maxillofac Surg, 69, 84, 10.1016/j.joms.2010.07.014

Pautke, 2011, Bisphosphonate related osteonecrosis of the jaw – manifestation in a microvascular iliac bone flap, Oral Oncol, 47, 425, 10.1016/j.oraloncology.2011.03.022

Pautke, 2012, Bisphosphonate related osteonecrosis of the jaw: a minipig large animal model, Bone, 51, 592, 10.1016/j.bone.2012.04.020

Phal, 2007, Imaging findings of bisphosphonate-associated osteonecrosis of the jaw, Am J Neuroradiol, 28, 1139, 10.3174/ajnr.A0518

Ralston, 1989, Comparison of three intravenous bisphosphonates in cancer associated hypercalcemia, Lancet, 334, 1180, 10.1016/S0140-6736(89)91791-1

Ruggiero S.L., Dodson T.B., Fantasia J., Goodday R., Aghaloo T., Mehrotra B., et al. Medication-Related Osteonecrosis of the Jaw – 2014 update. Position paper. www.aaoms.org/docs/position_paper (last accessed June 2014)

Sacco, 2011, A systematic review of microsurgical reconstruction of the jaw using vascularised fibula flap technique in patients with bisphosphonate-related osteonecrosis, J Appl Oral Sci, 19, 293, 10.1590/S1678-77572011000400001

Santos-Silva, 2013, Osteonecrosis of the mandible associated with bevacizumab therapy, Oral Surg Oral Med Oral Pathol Oral Radiol, 115, e32, 10.1016/j.oooo.2013.02.001

Schaudinn, 2012, Quantification by energy dispersive X-ray spectroscopy of alendronate in the diseased jaw bone of patients with bisphosphonate-related jaw necrosis, Oral Surg Oral Med Oral Pathol Oral Radiol, 114, 480, 10.1016/j.oooo.2012.06.006

Schirmer, 2005, Bisphosphonate und Osteonekrosen im Kieferbereich, Mund Kiefer GesichtsChir, 9, 239, 10.1007/s10006-005-0616-6

Sedghizadeh, 2008, Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy, J Oral Maxillofac Surg, 66, 767, 10.1016/j.joms.2007.11.035

Sedghizadeh, 2009, Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy, J Am Dent Assoc, 140, 1259, 10.14219/jada.archive.2009.0049

Seth, 2010, Outcomes of vascularized bone graft reconstruction of the mandible in bisphosphonate-related osteonecrosis of the jaws, Laryngoscope, 120, 2165, 10.1002/lary.21062

Shinoda, 1983, Structure-activity relationships of various bisphosphonates, Calcif Tissue Int, 35, 87, 10.1007/BF02405012

Silverman, 2009, Osteonecrosis of the jaw and the role of bisphosphonates: a critical review, A J Med, 122, S33, 10.1016/j.amjmed.2008.12.005

Sivolella, 2013, Denosumab and anti-angiogenetic drug-related osteonecrosis of the jaw: an uncommon but potentially severe disease, Anticancer Res, 33, 1793

Stefanik, 2008, Disparate osteogenic response of mandible and iliac crest bone marrow stromal cells to pamidronate, Oral Dis, 14, 465, 10.1111/j.1601-0825.2007.01402.x

Stockmann, 2010, Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study, Clin Oral Investig, 14, 311, 10.1007/s00784-009-0293-1

Stockmann, 2010, Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow up, Support Care Cancer, 18, 449, 10.1007/s00520-009-0688-1

Straub, 2014, Interaction of the endocrine system with inflammation: a function of energy and volume regulation, Arthritis Res Ther, 16, 203, 10.1186/ar4484

Taylor, 2010, Osteonecrosis of the jaws induced by anti-RANK ligand therapy, Br J Oral Maxillofac Surg, 48, 221, 10.1016/j.bjoms.2009.08.030

Toshihiro, 2013, Applicability of buccal fat pad grafting for oral reconstruction, Int J Oral Maxillofac Surg, 42, 604, 10.1016/j.ijom.2012.07.009

Treister, 2009, Dental panoramic radiographic evaluation in bisphosphonate-associated osteonecrosis of the jaws, Oral Dis, 15, 88, 10.1111/j.1601-0825.2008.01494.x

Treister, 2010, Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 109, 753, 10.1016/j.tripleo.2009.12.005

Vercruysse, 2014, Outcomes of osseous free flap reconstruction in stage III bisphosphonate-related osteonecrosis of the jaw: systematic review and a new case series, J Craniomaxillofac Surg, 42, 377, 10.1016/j.jcms.2014.01.005

Voss, 2012, Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients, J Craniomaxillofac Surg, 40, 719, 10.1016/j.jcms.2012.01.005

Walter, 2007, Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis, Supp Care Cancer, 15, 197, 10.1007/s00520-006-0120-z

Walter, 2010, Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients, Head Face Med, 8, 11, 10.1186/1746-160X-6-11

Wehrhan, 2011, Msx-I is suppressed in bisphosphonate-exposed jaw bone analysis of the bone turnover-related cell signalling after bisphosphonate treatment, Oral Dis, 17, 433, 10.1111/j.1601-0825.2010.01778.x

Wehrhan, 2011, Bisphosphonate-associated osteonecrosis of the jaw is linked to suppressed TGFβ 1-signaling and increased Galectin-3 expression: a histological study on biopsies, J Transl Med, 9, 102, 10.1186/1479-5876-9-102

Wehrhan, 2011, Differential impairment of vascularization and angiogenesis in bisphosphonate-associated osteonecrosis of the jaw-related mucoperiosteal tissue, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 112, 216, 10.1016/j.tripleo.2011.02.028

Wilde, 2009, Positron-emission tomography imaging in the diagnosis of bisphosphonate-related osteonecrosis of the jaw, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 107, 412, 10.1016/j.tripleo.2008.09.019

Wilde, 2011, The role of surgical therapy in the management of intravenous bisphosphonate-related osteonecrosis of the jaw, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 111, 153, 10.1016/j.tripleo.2010.04.015

Wilkinson, 2007, Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis, J Natl Cancer Inst, 99, 1016, 10.1093/jnci/djm025

Wutzl, 2008, Treatment results of bisphosphonate-related osteonecrosis of the jaws, Head Neck, 30, 1224, 10.1002/hed.20864

Yamada, 2014, Current trends in stem cell therapy for improvement of bone quality, Histol Histopathol, 29, 691

Yoneda, 2010, J Bone Miner Metab, 28, 365, 10.1007/s00774-010-0162-7

Zervas, 2006, Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients, Br J Haematol, 134, 620, 10.1111/j.1365-2141.2006.06230.x

Ziegler, 1998, Odontogener Fokus als Ursache zerebraler Ischämien, Mund Kiefer GesichtsChir, 2, 316, 10.1007/s100060050079